Pfizer Launches Academic Network

  • Author: ChemistryViews (Image © Tim Fonseca)
  • Published: 17 November 2010
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Pfizer Inc.
  • Associated Suppliers: Pfizer, New York, USA
thumbnail image: Pfizer Launches Academic Network

Pfizer is forming a network of academic collaborators, Pfizer's Global Centers for Therapeutic Innovation (CTI), based in Cambridge, MA, USA. Pfizer hopes to have between seven and eight partners in its network, which will focus solely on developing biologics-based drugs. Three or four of the partners will be based in the U.S., one or two in Europe, and the remaining in Asia or Australia.

The University of California, San Francisco (UCSF), CA, USA, has signed on as the first partner. Pizer will open labs adjacent to the UCSF campus, with 25 to 30 Pfizer scientists eventually working alongside university scientists to find new biologics targeting a range of diseases. Scientists will have access to Pfizer's phage display libraries and other research tools.

The next two partners, leading academic institutions based in Boston and New York City, are expected to be announced before the end of the year.


Article Views: 2754

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH